243 related articles for article (PubMed ID: 27671810)
41. Anticancer Activity of Curcumin and Its Analogues: Preclinical and Clinical Studies.
Allegra A; Innao V; Russo S; Gerace D; Alonci A; Musolino C
Cancer Invest; 2017 Jan; 35(1):1-22. PubMed ID: 27996308
[TBL] [Abstract][Full Text] [Related]
42. Anticancer and carcinogenic properties of curcumin: considerations for its clinical development as a cancer chemopreventive and chemotherapeutic agent.
López-Lázaro M
Mol Nutr Food Res; 2008 Jun; 52 Suppl 1():S103-27. PubMed ID: 18496811
[TBL] [Abstract][Full Text] [Related]
43. Molecular understanding of curcumin in diabetic nephropathy.
Soetikno V; Suzuki K; Veeraveedu PT; Arumugam S; Lakshmanan AP; Sone H; Watanabe K
Drug Discov Today; 2013 Aug; 18(15-16):756-63. PubMed ID: 23651956
[TBL] [Abstract][Full Text] [Related]
44. Curcumin and obesity.
Bradford PG
Biofactors; 2013; 39(1):78-87. PubMed ID: 23339049
[TBL] [Abstract][Full Text] [Related]
45. An update on Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Bar-Sela G
Curr Opin Clin Nutr Metab Care; 2015 Nov; 18(6):605-11. PubMed ID: 26418821
[TBL] [Abstract][Full Text] [Related]
46. Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials.
Strimpakos AS; Sharma RA
Antioxid Redox Signal; 2008 Mar; 10(3):511-45. PubMed ID: 18370854
[TBL] [Abstract][Full Text] [Related]
47. Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment.
Naksuriya O; Okonogi S; Schiffelers RM; Hennink WE
Biomaterials; 2014 Mar; 35(10):3365-83. PubMed ID: 24439402
[TBL] [Abstract][Full Text] [Related]
48. Research on curcumin: A meta-analysis of potentially malignant disorders.
Ara SA; Mudda JA; Lingappa A; Rao P
J Cancer Res Ther; 2016; 12(1):175-81. PubMed ID: 27072233
[TBL] [Abstract][Full Text] [Related]
49. Multiple antidepressant potential modes of action of curcumin: a review of its anti-inflammatory, monoaminergic, antioxidant, immune-modulating and neuroprotective effects.
Lopresti AL; Hood SD; Drummond PD
J Psychopharmacol; 2012 Dec; 26(12):1512-24. PubMed ID: 23035031
[TBL] [Abstract][Full Text] [Related]
50. Discovery of curcumin, a component of golden spice, and its miraculous biological activities.
Gupta SC; Patchva S; Koh W; Aggarwal BB
Clin Exp Pharmacol Physiol; 2012 Mar; 39(3):283-99. PubMed ID: 22118895
[TBL] [Abstract][Full Text] [Related]
51. Enhanced anti-cancer and antimicrobial activities of curcumin nanoparticles.
Adahoun MA; Al-Akhras MH; Jaafar MS; Bououdina M
Artif Cells Nanomed Biotechnol; 2017 Feb; 45(1):98-107. PubMed ID: 26747522
[TBL] [Abstract][Full Text] [Related]
52. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
Sahebkar A
Biofactors; 2013; 39(2):197-208. PubMed ID: 23239418
[TBL] [Abstract][Full Text] [Related]
53. Curcumin and its promise as an anticancer drug: An analysis of its anticancer and antifungal effects in cancer and associated complications from invasive fungal infections.
Chen J; He ZM; Wang FL; Zhang ZS; Liu XZ; Zhai DD; Chen WD
Eur J Pharmacol; 2016 Feb; 772():33-42. PubMed ID: 26723514
[TBL] [Abstract][Full Text] [Related]
54. Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells.
Zhao G; Han X; Zheng S; Li Z; Sha Y; Ni J; Sun Z; Qiao S; Song Z
Oncol Rep; 2016 Feb; 35(2):1065-74. PubMed ID: 26573768
[TBL] [Abstract][Full Text] [Related]
55. Curcumin inhibits cancer progression through regulating expression of microRNAs.
Zhou S; Zhang S; Shen H; Chen W; Xu H; Chen X; Sun D; Zhong S; Zhao J; Tang J
Tumour Biol; 2017 Feb; 39(2):1010428317691680. PubMed ID: 28222667
[TBL] [Abstract][Full Text] [Related]
56. Curcumin therapeutic promises and bioavailability in colorectal cancer.
Shehzad A; Khan S; Shehzad O; Lee YS
Drugs Today (Barc); 2010 Jul; 46(7):523-32. PubMed ID: 20683505
[TBL] [Abstract][Full Text] [Related]
57. Curcumin: a modulator of inflammatory signaling pathways in the immune system.
Kahkhaie KR; Mirhosseini A; Aliabadi A; Mohammadi A; Mousavi MJ; Haftcheshmeh SM; Sathyapalan T; Sahebkar A
Inflammopharmacology; 2019 Oct; 27(5):885-900. PubMed ID: 31140036
[TBL] [Abstract][Full Text] [Related]
58. Zinc-curcumin based complexes in health and diseases: An approach in chemopreventive and therapeutic improvement.
Prasad S; Lall R
J Trace Elem Med Biol; 2022 Sep; 73():127023. PubMed ID: 35780653
[TBL] [Abstract][Full Text] [Related]
59. Curcumin, a component of golden spice: from bedside to bench and back.
Prasad S; Gupta SC; Tyagi AK; Aggarwal BB
Biotechnol Adv; 2014 Nov; 32(6):1053-64. PubMed ID: 24793420
[TBL] [Abstract][Full Text] [Related]
60. [Curcumin in the treatment of prostatic diseases].
Chen ZQ; Mo ZN
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):67-70. PubMed ID: 18297817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
